96961 Items found

Search Products:

Enter Catalogue #, CAS # , Chemical Name or Mol Formula:
  • SYA100800
    A-1155463 Hydrochloride
    C35H32FN5O4S2•HCl
    2-[8-[(2-Benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-[4-[3-(dimethylamino)-1-propyn-1-yl]-2-fluorophenoxy]propyl]-4-thiazolecarboxylic Acid Hydrochloride;
  • SYA100803
    O-1821
    35482-50-9
    C17H22O2
    5-Methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol;(1R-trans)-5-Methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol; Cannabidiorcol; Cannabidiorocol
  • SYA100900
    A-1331852
    1430844-80-6
    C38H38N6O3S
    6-[8-[(2-Benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-3-[5-methyl-1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-pyrazol-4-yl]-2-pyridinecarboxylic Acid
  • SYA101010
    A350619 Hydrochloride
    1217201-17-6
    C21H26Cl2N2OS
    3-[2-[(4-Chlorophenyl)thio]phenyl]-N-[4-(dimethylamino)butyl]-2-propenamide, , Hydrochloride;
  • SYA101025
    A-366
    1527503-11-2
    C19H27N3O2
    5’-Methoxy-6’-[3-(1-pyrrolidinyl)propoxy]-spiro[cyclobutane-1,3’-[3H]indol]-2’-amine,
  • SYA101030
    A 37203
    220519-06-2
    C20H27F3N6OS
    Lu 201640; 2-[[3-[4-[2-(1,1-Dimethylethyl)-6-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinyl]propyl]thio]-4(3H)-pyrimidinone; 2-[[3-[4-[2-(1,1-Dimethylethyl)-6-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinyl]propyl]thio]-4(1H)-pyrimidinone
  • SYA101040
    A 419259 Trihydrochloride
    1435934-25-0
    C29H34N6O•3HCl
    7-[trans-4-(4-Methyl-1-piperazinyl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Hydrochloride; A-419259 Trihydrochloride
  • SYA101042
    A 419259 Trihydrochloride-D3
    C29H31D3N6O•3HCl
    Trideuterated A 419259 Trihydrochloride
  • SYA101050
    A 54556B
    1629166-56-8
    C37H48N6O8
    A 54556 factor B; A 54556B; Antibiotic A 54556B; N-​[(2E,​4E,​6E)​-​1-​Oxo-​2,​4,​6-​octatrien-​1-​yl]​-​L-​phenylalanyl-​L-​seryl-​L-​prolyl-​N-​methyl-​L-​alanyl-​L-​alanyl-​L-​proline (6→2)​-​lactone
  • SYA101055
    A 54556A (~90%)
    95398-45-1
    C38H50N6O8
    (4R)-N-[(2E,4E,6E)-1-oxo-2,4,6-Octatrien-1-yl]-L-phenylalanyl-L-seryl-L-prolyl-N-methyl-L-alanyl-L-alanyl-4-methyl-L-proline (6→2)-lactone; A 54556 factor A; ADEP 1; Acyldepsipeptide 1; Acyldepsipeptide A; Antibiotic A 54556A
  • SYA101090
    A 61603
    107756-30-9
    C15H21BrN2O3S
    N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-2-hydroxy-1-naphthalenyl]methanesulfonamide Monohydrobromide; N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-5,6,7,8-tetrahydro-2-hydroxy-1-naphthalenyl]methanesulfonamide Hydrobromide
  • SYA101100
    A66
    1166227-08-2
    C17H23N5O2S2
    (2S)-N1-[2-(1,1-Dimethylethyl)-4’-methyl[4,5’-bithiazol]-2’-yl]-1,2-pyrrolidinedicarboxamide; (2S)-1-N-[5-(2-tert-Butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide
  • SYA101200
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • SYA101205
    A 769662
    844499-71-4
    C20H12N2O3S
    4-Hydroxy-3-(2’-hydroxy-1,1’-biphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile; 6,7-Dihydro-4-hydroxy-3-(2’-hydroxy[1,1’-biphenyl]-4-yl)-6-oxo-thieno[2,3-b]pyridine-5-carbonitrile
  • SYA101210
    A 83-01
    909910-43-6
    C25H19N5S
    3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide
  • SYA101230
    A 844606
    861119-08-6
    C20H20N2O2
    2-(Hexahydro-5-methylpyrrolo[3,4-c]pyrrol-2(1H)-yl)-9H-xanthen-9-one; 2-(7-Methyl-3,7-diazabicyclo[3.3.0]octan-3-yl)xanthen-9-one;
  • SYA101250
    A-887826
    1266212-81-0
    C26H29ClN4O3
    5-(4-Butoxy-3-chlorophenyl)-N-[[2-(4-morpholinyl)-3-pyridinyl]methyl]-3-pyridinecarboxamide; A 887826;
  • SYA101252
    A-887826-d8
    1794753-88-0
    C26H21D8ClN4O3
    5-(4-Butoxy-3-chlorophenyl)-N-[[2-(4-morpholinyl-d8)-3-pyridinyl]methyl]-3-pyridinecarboxamide; A 887826-d8;
  • SYA104460
    AAL Toxin TE2
    176590-38-8
    C27H49NO9
    (2R)​-1-​[(1R,​2S,​4S,​13S)​-​14-​(Acetylamino)​-​2,​13-​dihydroxy-​4-​methyl-​1-​[(1R)​-​1-​methylpropyl]​tetradecyl]ester-1,​2,​3-​Propanetricarboxylic Acid;
  • SYA104465
    AAL Toxin TD2
    176590-36-6
    C27H49NO10
    (2R)​-1-​[(1R,​2S,​4S,​11R,​13S)​-​14-​(Acetylamino)​-​2,​11,​13-​trihydroxy-​4-​methyl-​1-​[(1R)​-​1-​methylpropyl]​tetradecyl]ester-1,​2,​3-​propanetricarboxylic Acid;
  • SYA104470
    AAL Toxin TD1
    176590-35-5
    C27H49NO10
    (2R)​-1-​[(1S,​3S,​10R,​12S)​-​13-​(Acetylamino)​-​10,​12-​dihydroxy-​1-​[(1R,​2R)​-​1-​hydroxy-​2-​methylbutyl]​-​3-​methyltridecyl]ester-1,​2,​3-​propanetricarboxylic Acid;
  • SYA104475
    AAL Toxin TC2
    176590-34-4
    C25H47NO8
    AAL Toxin TC2; [1R-[1R*(R*),1(R*),2S*,4S*,13S*]]-1-[14-Amino-2,13-dihydroxy-4-methyl-1-(1-methylpropyl)tetradecyl]ester-1,2,3-Propanetricarboxylic Acid; (2R)​-1-​[(1R,​2S,​4S,​13S)​-​14-​Amino-​2,​13-​dihydroxy-​4-​methyl-​1-​[(1R)​-​1-​methylpropyl]​tetradecyl]ester-1,​2,​3-​Propanetricarboxylic Acid;
  • SYA104480
    AAL Toxin TB1
    176590-32-2
    C25H47NO9
    TB1; [1S-[1R*(S*),1(1S*,2S*),3R*,10S*,12R*]]-1-[13-Amino-10,12-dihydroxy-1-(1-hydroxy-2-methylbutyl)-3-methyltridecyl]ester-1,2,3-Propanetricarboxylic Acid;
  • SYA104485
    AAL Toxin TA2
    79367-51-4
    C25H47NO10
    [1R-[1R*(R*),1(R*),2S*,4S*,10R*,11S*,13S*]]-1-[14-Amino-2,10,11,13-tetrahydroxy-4-methyl-1-(1-methylpropyl)tetradecyl]ester-1,2,3-propanetricarboxylic Acid; Alternaria Alternata Toxin TA2; (2R)​-​[(1R,​2S,​4S,​10R,​11S,​13S)​-​14-​Amino-​2,​10,​11,​13-​tetrahydroxy-​4-​methyl-​1-​[(1R)​-​1-​methylpropyl]​tetradecyl]ester-1,​2,​3-​Propanetricarboxylic Acid;
  • SYA104490
    AAL-993
    269390-77-4
    C20H16F3N3O
    ZK260253; 2-​​[(4-​​Pyridinylmethyl)​amino]​-​​N-​​[3-​​(trifluoromethyl)​phenyl]​benzamide; 2-((Pyridin-4-ylmethyl)amino)-N-(3-(trifluoromethyl)phenyl)benzamide
  • SYA104495
    AAEM Resin (Acetoacetoxyethyl Ketoester Resin)
    34500-18-0
    N/A
  • SYA104500
    AB-005
    895155-25-6
    C23H32N2O
    [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
  • SYA104505
    ---
    ---
    ---
    ---
    This is a controlled substance:Pending Status
  • SYA104507
    AB-005 Azepane Isomer-D4
    C23H29D3N2O
    [1-(Hexahydro-1-methyl-1H-azepin-3-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone-D4
  • SYA104985
    Abacavir 5’-β-D-Glucuronide Sodium Salt
    C20H25N6NaO7
    [(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl]methyl-β-D-Glucopyranosiduronic Acid Sodium Salt; Abacavir 5’-Glucuronide Sodium Salt
  • SYA104990
    Abacavir
    136470-78-5
    C14H18N6O
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (1S-cis)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; 1592U89; ABC;
  • SYA104995
    trans-Abacavir Hydrochloride
    267668-71-3
    C14H19ClN6O
    (1R,4R)-rel-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Hydrochloride;
  • SYA104997
    trans-Abacavir-d4 Hydrochloride
    C14H15D4ClN6O
    (1R,4R)-rel-4-[2-Amino-6-[cyclopropyl-d4)amino]-9H-purin-9-yl]-2-cyclopentene-1-methanol Hydrochloride;
  • SYA105000
    Abacavir Sulfate
    188062-50-2
    C28H38N12O6S
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Sulfate; Ziagen;
  • SYA105002
    Abacavir-d4
    C14H14D4N6O
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino-d4)-9H-purin-9-yl]-2-cyclopentene-1-methanol;(1S-cis)-4-[2-Amino-6-(cyclopropylamino-d4)-9H-purin-9-yl]-2-cyclopentene- 1-methanol; 1592U89-d4; ABC-d4;
  • SYA105005
    Abacavir Carboxylate
    384380-52-3
    C14H16N6O2
    (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-carboxylic Acid; 2269W;
  • SYA105015
    ent-Abacavir
    136470-79-6
    C14H18N6O
    (1R,4S)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (1R-cis)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; (1R,4S)-Abacavir;
  • SYA105020
    Abacavir 5’-Phosphate
    136470-77-4
    C14H19N6O4P
    (1S,4R)- 4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Dihydrogen Phosphate (Ester); (1S-cis)-Abacavir Monophosphate;
  • SYA105025
    rac-Abacavir Sulfate
    C28H38N12O6S
    Abacavir Sulfate Racemic; (4-[2-Amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol Sulfate (2:1);
  • SYA105030
    Abacavir 5’-(2,3,4-Tri-O-isobytyryl)-β-D-glucuronic Acid Methyl Ester
    C33H46N6O10
  • SYA105035
    Abacavir 5’-4-Chloro-6-methylpyrimidine-2,5-diamine
    1443421-69-9
    C18H21ClN10O
    N6-Cyclopropyl-9-((1R,4S)-4-(((2,5-diamino-6-chloropyrimidin-4-yl)oxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine; Abacavir Related Compound D
  • SYA105037
    Abacavir-d4 5’-4-Chloro-6-methylpyrimidine-2,5-diamine
    C18H17D4ClN10O
    N6-Cyclopropyl-d4-9-((1R,4S)-4-(((2,5-diamino-6-chloropyrimidin-4-yl)oxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine; Abacavir-d4 Related Compound D
  • SYA105040
    Abacavir Triphosphate Trisodium Salt
    C14H18N6Na3O10P3
    P-[[(2S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl]methyl]ester Triphosphate Trisodium Salt
  • SYA105050
    AB-CHMICA
    C21H29N3O2
  • SYA105960
    AB-CHMINACA
    1185887-21-1
    C20H28N4O2
    N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide; (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
  • SYA105970
    AB-CHMINACA 2’-Indazole Isomer RM
    C20H28N4O2
    (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2H-indazole-3-carboxamide;
  • SYA105975
    AB-CHMINACA Metabolite M1A
    C20H28N4O3
    N-((S)-1-Amino-3-methyl-1-oxobutan-2-yl)-1-((3-hydroxycyclohexyl)methyl)-1H-indazole-3-carboxamide;
  • SYA105980
    AB-CHMINACA Metabolite M1B
    C20H28N4O3
    (S)-N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1H-indazole-3-carboxamide;
  • SYA105995
    AB-CHMINACA metabolite M2
    1185887-51-7
    C20H27N3O3
    N-[[1-(Cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-L-valine;
  • SYA106000
    AB-CHMINACA Metabolite M2 Methyl Ester
    1971007-96-1
    C21H31N3O3
    AMB N-Methylcyclohexyl Analog; Methyl [(1S)-(Cyclohexylmethyl)-1H-indazole-3-carbonyl]-L-valinate
  • SYA106005
    AB-CHMINACA metabolite M3A
    C20H27N3O4
    (1-((4-Hydroxycyclohexyl)methyl)-1H-indazole-3-carbonyl)-L-valine;
  • SYA106009
    AB-CHMINACA metabolite M4-d4
    C15H14D4N2O2
    1-(Cyclohexylmethyl)-1H-indazole-3-carboxylic-d4 Acid; AB-CHMINACA M4-d4;
  • SYA106010
    AB-CHMINACA metabolite M5A
    C15H18N2O3
    1-((4-hydroxycyclohexyl)methyl)-1H-indazole- 3-carboxylic Acid
  • SYA106025
    AB-CHMINACA metabolite M7
    C20H25N3O5
    2-(1-(Cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinic Acid
  • SYA106525
    ABP 688
    924298-51-1
    C15H16N2O
    O-3-[2-(6-Methyl-2-pyridinyl)ethynyl]-methyloxime-2-cyclohexen-1-one;
  • SYA107000
    Abamectin
    71751-41-2
    C48H72O14
    Avermectin B1; MK-936; Agri-Mek; Avid; Zephyr;
  • SYA107005
    8,9-Z-Abamectin B1a
    113665-89-7
    C48H72O14
    (8Z)-5-O-Demethylavermectin A1a; Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran] Avermectin A1a Deriv.
  • SYA107010
    Abamectin B1b
    65195-56-4
    C47H70O14
    5-O-Demethyl-25-de(1-methylpropyl)-25-(1-methylethyl)-avermectin A1a; Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran] Avermectin A1a Derivative; Abamectin Component B1b; Antibiotic C 076B1b; Avermectin B1b;
  • SYA107200
    Abamine
    729612-64-0
    C21H24FNO4
    N-[(2E)-3-(3,4-Dimethoxyphenyl)-2-propen-1-yl]-N-[(4-fluorophenyl)methyl]-glycine Methyl Ester; N-[(2E)-3-(3,4-Dimethoxyphenyl)-2-propenyl]-N-[(4-fluorophenyl)methyl]-glycine Methyl Ester
  • SYA107225
    Abarelix
    183552-38-7
    C72H95ClN14O14
    17: PN: WO2007012430 SEQID: 19 claimed protein; 1: PN: WO02056903 PAGE: 25 claimed protein; 5: PN: WO0018423 PAGE: 26 claimed protein; Abarelix; PPI 149; Plenaxis; R 3827; N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-D-alaninamide
  • SYA107228
    Abafungin
    129639-79-8
    C21H22N4OS
    N-[4-[2-(2,4-Dimethylphenoxy)phenyl]-2-thiazolyl]-1,4,5,6-tetrahydro-2-pyrimidinamine; BAY-W 6341
  • SYA107250
    Abbvie Mcl-1 Inhibitor
    1668553-26-1
    C46H55N7O7S
    7-(5-((4-(4-(N,N-Dimethylsulfamoyl)piperazin-1-yl)phenoxy)methyl)-1,3-dimethyl-1H-pyrazol-4-yl)-1-(2-morpholinoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic Acid
  • SYA107600
    (+)-cis-Abienol
    17990-16-8
    C20H34O
    (1R,2R,4aS,8aS)-Decahydro-2,5,5,8a-tetramethyl-1-[(2Z)-3-methyl-2,4-pentadien-1-yl]-2-naphthalenol; [1R-[1α(Z),2β,4aβ,8aα]]-Decahydro-2,5,5,8a-tetramethyl-1-(3-methyl-2,4-pentadienyl)-2-naphthalenol; (1R,2R,4aS,8aS)-Decahydro-2,5,5,8a-tetramethyl-1-[(2Z)-3-methyl-2,4-pentadienyl]-2-naphthalenol; (Z)-Labda-12,14-dien-8-ol; (12Z)-Abienol; (Z)-Abienol; (8R)-cis-Labda-12,14-dien-8-ol, ; cis-Abienol; Δ12-cis-Abienol
  • SYA108190
    8,13(15)-Abietadienoic Acid
    19402-33-6
    C20H30O2
    (1R,4aS,10aR)-1,2,3,4,4a,5,6,7,8,9,10,10a-Dodecahydro-1,4a-dimethyl-7-(1-methylethylidene)-1-Phenanthrenecarboxylic Acid; [1R-(1α,4aβ,10aα)]-1,2,3,4,4a,5,6,7,8,9,10,10a-Dodecahydro-1,4a-dimethyl-7-(1-methylethylidene)-1-phenanthrenecarboxylic Acid; 13-Isopropylidene-podocarp-8-en-15-oic Acid; Δ8,13(15)-Abietic Acid
  • SYA108200
    Abietic Acid, 75%
    514-10-3
    C20H30O2
    (1R,4aR,4bR,10aR)-1,2,3,4,4a,4b,5,6,10,10a-Decahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic Acid; 13-Isopropylpodocarpa-7,13-dien-15-oic Acid; (-)-Abietic Acid; 7,13-Abietadien-18-oic Acid; Abietic Acid; NSC 25149; Odomit B 10; Sylvic Acid; ZAO; l-Abietic Acid;
  • SYA108203
    Abietic Acid, >95%
    514-10-3
    C20H30O2
    (1R,4aR,4bR,10aR)-1,2,3,4,4a,4b,5,6,10,10a-Decahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic Acid; 13-Isopropylpodocarpa-7,13-dien-15-oic Acid; (-)-Abietic Acid; 7,13-Abietadien-18-oic Acid; Abietic Acid; NSC 25149; Odomit B 10; Sylvic Acid; ZAO; l-Abietic Acid;
  • SYA108205
    Abietic Acid Diamylamine
    881185-17-7
    C20H30O2•C9H21N
    (1R,4aR,4bR,10aR)-1,2,3,4,4a,4b,5,6,10,10a-Decahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic Acid Compd. with N-Pentyl-1-pentanamine; (1R,4aR,4bR,10aR)- 1,2,3,4,4a,4b,5,6,10,10a-Decahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic Acid Compd. with N-Pentyl-1-pentanamine;
  • SYA108485
    ---
    ---
    ---
    ---
    This is a controlled substance:Next for Status
  • SYA108490
    Abiraterone
    154229-19-3
    C24H31NO
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; CB 7598;
  • SYA108492
    Abiraterone-d4
    C24H27D4NO
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
  • SYA108495
    Abiraterone β-D-Glucuronide
    C30H39NO7
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol β-D-Glucuronide;
  • SYA108500
    Abiraterone Acetate
    154229-18-2
    C26H33NO2
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester); CB 7630;
  • SYA108502
    Abiraterone Acetate-d4
    C26H29D4NO2
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate-d4 (Ester); CB 7630-d4;
  • SYA108505
    Abiraterone Tosylate
    C31H37NO3S
  • SYA108510
    Abiraterone Acetate N-Oxide
    C26H33NO3
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester) N-Oxide; CB 7630 N-Oxide;
  • SYA108515
    Abiraterone Sulfate Sodium Salt
    C24H30NNaO4S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Sulfate Sodium;
  • SYA108520
    Abiraterone N-Oxide Sulfate
    C24H31NO5S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol N-Oxide Sulfate;
  • SYA108525
    Abiraterone Ethyl Ether
    C26H35NO
    3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • SYA108527
    Abiraterone Ethyl Ether-d5
    C26H30D5NO
    3-((3S,8R,9S,10R,13S,14S)-3-ethoxy--d5-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • SYA108530
    Abiraterone Isopropyl Ether
    C27H37NO
    3-((3S,8R,9S,10R,13S,14S)-3-Isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • SYA108532
    Abiraterone Isopropyl Ether-d7
    C27H30D7NO
    3-((3S,8R,9S,10R,13S,14S)-3-Isopropoxy-d7-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • SYA108535
    Abiaterone-5,6-epoxide
    C24H33NO2
    5,6-Epoxy Abiaterone
  • SYA108540
    Abiraterone N-Oxide
    C24H31NO2
  • SYA108545
    (3β)-16-[(3β)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
    186826-70-0
    C43H57NO2
  • SYA108550
    (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
    186826-68-6
    C47H61NO4
    (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol Acetate (ester)
  • SYA108555
    3,5-cyclo-Abiraterone
    C24H31NO
  • SYA108910
    Abnormal Cannabidiol
    22972-55-0
    C21H30O2
    4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; CAY10429; trans-(-)-4-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; trans-(-)-4-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
  • SYA108912
    Abnormal Cannabidiol-d9
    C21H21D9O2
    4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9; CAY10429; trans-(-)-4-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol-d9; trans-(-)-4-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9
  • SYA108980
    ---
    ---
    ---
    ---
    This is a controlled substance:Pending Status
  • SYA109000
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • SYA109002
    AB-PINACA-d9
    C18H17D9N4O2
    (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(pentyl-2,2’,3,3’,4,4’,5,5,5-d9)-1H-indazole-3-carboxamide
  • SYA109005
    AB-PINACA N-(5-Hydroxypentyl) Metabolite
    C18H26N4O3
    N-(1-Amino-3-methyl-1-oxobutn-2-yl)-1-(5-hydroxypentyl)-1H-indazole-3-carboxamide
  • SYA109010
    AB Pinaca 5-Pentanoic Acid
    1630022-93-3
    C18H24N4O4
    3-[[[(1S)-1-(Aminocarbonyl)-2-methylpropyl]amino]carbonyl]-1H-indazole-1-pentanoic Acid;
  • SYA109095
    Abscisic Acid Methyl Ester
    60102-39-8
    C16H22O4
    (+)-Methyl Abscisate; (S)-Abscisic Acid Methyl Ester; 5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester
  • SYA110000
    (+)-cis,trans-Abscisic Acid, 98%
    21293-29-8
    C15H20O4
    (S-(Z,E)])-5-(1-Hydroxy-2,6,6-trimethyl)-4-oxo-2-cyclohexen-1-yl-3-methyl-2,4-pentadienoic Acid; (+)-(S)-Abscisic Acid; (+)-(cis,trans)-Abscisic Acid; (+)-ABA; S-ABA; Dormin;
  • SYA110002
    (+)-cis,trans-Abscisic Acid-d6
    721948-65-8
    C15H14D6O4
    [S-(Z,E)]-5-[1-Hydroxy-6,6-dimethyl-2-(methyl-d6)-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid; S-ABA-d6; Dormin-d6;
  • SYA110005
    (+)-Abscisic Aldehyde
    41944-86-9
    C15H20O3
    (2Z,4E)-5-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienal; (+)-Abscisyl aldehyde; Abscisic Aldehyde
  • SYA110010
    rac 8’-Acetylene Abscisic Acid Methyl Ester
    192987-96-5
    C17H20O4
    (2Z,4E)-rel-5-[(1R,6R)-6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid Methyl Ester; PBI 429;
  • SYA110015
    (±)-Abscisic Aldehyde
    29448-38-2
    C15H20O3
    (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4- pentadienal; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)- 3-methyl-2,4-pentadienal; PBI 37
  • SYA110017
    (±)-Abscisic Aldehyde-d3
    C15H17D3O3
    (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4- pentadienal-d3; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)- 3-methyl-2,4-pentadienal-d3; PBI 37-d3;
96961 Items found
Translate »